Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNV4818 in Advanced Solid Tumors
NCT06736704Phase 2Recruiting
- Sponsor
- Pikavation Therapeutics, Inc.
- Start
- Feb 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of SNV4818 in solid tumor (advanced stage), sponsored by Pikavation Therapeutics, Inc.. Started Feb 2025; status: recruiting.
02
Drugs
SNV4818
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06736704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06736704.